ArticleEmerging infectious diseases2022

Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.

Mars Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.